Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection by Kountouras, Jannis et al.








Helicobacter pylori infection and gastrointestinal tract cancer biology:
considering a double-edged sword reflection
Kountouras, Jannis ; Doulberis, Michael ; Papaefthymiou, Apostolis ; Polyzos, Stergios A ; Touloumtzi,
Maria ; Elisabeth, Vardaka ; Kapetanakis, Nikolaos ; Liatsos, Christos ; Gavalas, Emmanouel ;
Katsinelos, Panagiotis
DOI: https://doi.org/10.1007/s00018-019-03106-4





Kountouras, Jannis; Doulberis, Michael; Papaefthymiou, Apostolis; Polyzos, Stergios A; Touloumtzi,
Maria; Elisabeth, Vardaka; Kapetanakis, Nikolaos; Liatsos, Christos; Gavalas, Emmanouel; Katsinelos,
Panagiotis (2019). Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a
double-edged sword reflection. Cellular and Molecular Life Sciences, 76(13):2487-2488.
DOI: https://doi.org/10.1007/s00018-019-03106-4
 1 
Helicobacter pylori infection and gastrointestinal tract cancer biology: 
considering a double‑ edged sword reflection 
 
Jannis Kountouras, MD, PhD1, Michael Doulberis, MD, DVM, PhD1,2, Apostolis 
Papaefthymiou, MD1, Stergios A. Polyzos, MD, Msc, PhD3, Maria Touloumtzi, MD1, 
Vardaka Elisabeth, PhD1, Nikolaos Kapetanakis, MD, PhD1, Christos Liatsos MD,PhD1 
Emmanouel Gavalas, MD,PhD1, Panagiotis Katsinelos, MD, PhD1 
 
1Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, 
Ippokration Hospital, Thessaloniki 54642, Macedonia, Greece 
2Department of Gastroenterology and Hepatology, University of Zurich, Zurich 8091, 
Switzerland 
3First Department of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, 
Thessaloniki 54642, Macedonia, Greece 
 
Key words: Helicobacter pylori; gastrointestinal cancer; bone marrow-derived stem cell; 
microbiota; dysbiosis 
Financial support: None 
Potential competing interests: None 
Please address correspondence to: 
Jannis Kountouras, MD, PhD 
Professor of Medicine 
8 Fanariou St, Byzantio 
551 33, Thessaloniki, Macedonia 
Greece 





In their comprehensive review Mentis et al. [1] discussed some molecular biological mechanisms 
involved in Helicobacter pylori infection (Hp-I)-related gastric cancer (GC) biology such as the role of 
stem cells and the link between Hp-I and gastrointestinal microbiota (GI-M). Moreover, they posed some 
«unsolved conundrums» such as the following: Hp-I induces gastric and duodenal inflammation, but is 
only linked to GC. This claim, however, is incomplete, because Hp-I is also linked with duodenal 
adenomas/carcinomas [2]. Moreover, Hp-I induces lower GI tract inflammation, thereby promoting 
oncogenesis [3,4]. In this regard, we wish to add some additional data involving Hp-I in upper and lower 
GI tract oncogenesis.  
Concerning the role of stem cells in Hp-I-related GC, we earlier reviewed [5] mechanisms of Hp and 
stem cell interaction in GC such as: activation of the Wnt/β-catenin signaling pathway; CagA impact on 
the fibroblast growth factor signal pathways implicated in the development of GC; enhancing 
transforming growth factor-β/bone morphogenetic proteins signal pathway involved in GC cells invasion; 
sonic hedgehog signaling dysregulation; and recruitment of mesenchymal stem cells and/or bone 
marrow-derived stem cells (BMDSCs), also mentioned in one original study (2004) by the authors  [1], in 
the course of chronic inflammatory condition, that gains stepwise transformation to GC cells [5]. 
Likewise, such aforementioned mechanisms have been confirmed by more recent data [6], further 
indicated that Hp-I activates epithelial-mesenchymal transition pathway and induces the development of 
GC stem cells (CSCs), such as CD44(+) [7]. Regarding the latter aspect, by using CSC and/or BMDSCs 
marker CD44, the CD44(+) gastric CSCs appear to display the stem cell self-renewal properties. 
Moreover, Hp is responsible for CD44(+) increased expression, indicating a potential Hp induction of 
CD44(+) gastric CSCs implicated in gastric tumorigenesis [3]. Furthermore, our studies showed 
presence of cyclin D1 involved in GC cell proliferation, as well as CD34 expressed on hematopoietic 
stem cells and neovessels in human Hp-related GC specimens [8]. Beyond GC, our studies also 
showed CD44(+) augmented expression in human Hp-connected colorectal adenoma (CRA) and 
colorectal cancer (CRC) tissues [3]. Therefore, Hp-I could have an impact on colon oncogenesis by 
stimulating CSCs or recruiting BMDSCs, similar to upper GI Hp-I-connected chronic inflammation-
metaplasia-dysplasia sequence and BMDSCs recruitment that contribute to oncogenesis [3]. Thus 
further large-scale relative studies are warranted.  
 BMDSCs might also contribute to the pathogenesis of Barrett’s esophagus (BE) [9], a 
complication of gastroesophageal reflux disease (GERD), which predisposes to BE-related esophageal 
adenocarcinoma (EAC) development. In this concern, it has been proposed that chronic Hp-I induces 
atrophic gastritis accompanying by decreased acid secretion and acid reflux, thereby reducing the risk of 
GERD and its related BE and EAC. However, this conventional consideration might represent a 
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double‑ edged sword one view. Regarding the opposed view, the authors reported that Hp-I influences 
the GI-M composition including the presence of gastric species such as Campylobacter [1]. 
Hypochlorhydria induced by Hp-related atrophic gastritis, results in GI-M dysbiosis, which, beyond GC, 
could also contribute to BE-EAC sequence [10,11]. In this regard, Campylobacter, as main influential 
genera in Hp-connected atrophic gastritis specimens, and gastric atrophy-induced GM could contribute 
to gastric carcinogenesis [10]. Equally, data on BE biofilm show high atypical nitrate reducing 
Campylobacter species in BE which, via chronic inflammation, may contribute to the development of BE 
and/or its progression to EAC [11]. Therefore, Hp–induced Campylobacter species and dysbiosis, 
through chronic esophageal inflammation may lead to EAC development [11,12] and thus further 
investigation is needed.  
 Concerning the role of molecular events involved in Hp-I-related GERD-BE-EAC sequence, we 
also summarized [13] Hp relative pathogenic mechanisms such as: Hp induction of GI tract oncogenic 
gastrin, which stimulates Barrett's EAC cells proliferation via Janus Kinase (JAK)2 and Akt-dependent 
nuclear factor-kappa B (NF-κB) activation, displays a anti-apoptotic effect through Bcl-2 protein and 
survivin upregulation, and induces the mitogenic cyclooxygenase (COX)-2 expression that contributes to 
GI tract carcinogenesis. Specifically, COX-2 derived prostaglandins (PGs) contribute to BE-associated 
cancer progression, by perpetuating chronic inflammation. Likewise, the PGs mitogenic and 
antiapoptotic properties are mediated through activation of certain aforementioned signaling pathways 
including NF-κB, Sarcoma family protein tyrosine (Src), JAK2/Signal transducers and activators of 
transcription (STAT)3, Extracellular-signal Regulated (ERK), mitogen-activated protein (MARK) and 
phosphoinositide-3-kinase–protein kinase B (PI3K/Akt) kinases. Moreover, Hp-I could provoke specific 
molecular changes (genetic instability, E-cadherin methylation, monoclonal antibody Das-1) linked with 
BE pathophysiology, and promotes Ki-67 expression predicting BE malignant progression. Finally, Hp-
related metabolic syndrome disorders associated with GI-M dysbiosis also appear to be involved in GI 
tract carcinogenesis [13-15]. Therefore, Hp eradication might inhibit aforementioned oncogenic 
processes, and thus further studies are necessary. 
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